Showing results (251-260 of 376) with videos related to

Sort By:
Pageof 38
Advances in Radiation Oncology|February 7, 2022
Radiation Therapy in Conjunction With Surgical Stabilization of Impending or Pathologic Fractures Secondary to Metastasis: Is There a Difference Between Single and Multifraction Regimens?Ryan D Kraus, Christopher R Weil, Stacey Wells, et al.
American Journal of Physiology. Heart and Circulatory Physiology|February 23, 2010
Toll-like receptor 2 mediates mesenchymal stem cell-associated myocardial recovery and VEGF production following acute ischemia-reperfusion injuryAaron M Abarbanell, Yue Wang, Jeremy L Herrmann, et al.
JACC. Basic to Translational Science|June 25, 2025
Persistent Fibrosis and Left Ventricular Chamber Stiffening Despite Cessation of Repetitive Pressure Overload in SwineBrian R Weil, Luke Graser, Sailee Rasam, et al.
Atherosclerosis|May 7, 2013
Impaired fasting blood glucose is associated with increased endothelin-1 vasoconstrictor toneKyle J Diehl, Danielle L Templeton, Julie Ma, et al.
The Annals of Thoracic Surgery|September 28, 2011
Transforming growth factor-α enhances stem cell-mediated postischemic myocardial protectionJeremy L Herrmann, Aaron M Abarbanell, Yue Wang, et al.
Surgery|May 4, 2010
Mesenchymal stem cells attenuate myocardial functional depression and reduce systemic and myocardial inflammation during endotoxemiaBrent R Weil, Mariuxi C Manukyan, Jeremy L Herrmann, et al.
Head & Neck|November 26, 2022
Survival outcomes for patients with T3N0M0 squamous cell carcinoma of the glottis treated with definitive radiation alone versus chemoradiationCalvin B Rock, Ryan J Hutten, Chris R Weil, et al.
Pediatric Blood & Cancer|July 23, 2024
Current surgical approach: Extracranial malignant germ cell tumorsBarrie S Rich, Brent R Weil, Hatim Thaker, et al.
Shock (Augusta, Ga.)|December 3, 2009
TNF receptor 2, not TNF receptor 1, enhances mesenchymal stem cell-mediated cardiac protection following acute ischemiaMegan L Kelly, Meijing Wang, Paul R Crisostomo, et al.
Plos One|December 15, 2010
TLR4 inhibits mesenchymal stem cell (MSC) STAT3 activation and thereby exerts deleterious effects on MSC-mediated cardioprotectionYue Wang, Aaron M Abarbanell, Jeremy L Herrmann, et al.
Pageof 38